Biotech Week in Review: Progress in China BioPharma
Aggregated Source: China Stocks News and Analysis from Seeking AlphaLast week, a Q3 review of venture capital/private equity investing in
China showed robust activity in all sectors, including biopharma. In
the quarterly report of VC/PE investing firm Zero2IPO, the figures were
up in almost every metric, including the number of investments, the
amount of investments and the number of exits (see story).
Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha
Print This Post
|
Email This Page